UnitedHealth Group Incorporated $UNH Stock: Fischer Financial Services Inc. Lowers Holdings

Posted by Brenda Bartman on Nov 4th, 2026

Fischer Financial Services Inc. cut its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 39.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,117 shares of the healthcare conglomerate’s stock after selling 1,395 shares during the quarter. Fischer Financial Services Inc.’s holdings in UnitedHealth Group were worth $777,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of UNH. Wellington Altus USA Inc. increased its stake in shares of UnitedHealth Group by 97.1% in the second quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 33 shares during the period. Security National Bank of SO Dak bought a new stake in UnitedHealth Group in the second quarter valued at $29,000. Nvwm LLC raised its stake in UnitedHealth Group by 89.2% during the 3rd quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock worth $26,000 after buying an additional 33 shares during the period. Aberdeen Wealth Management LLC acquired a new stake in UnitedHealth Group in the 2nd quarter valued at $31,000. Finally, Compass Wealth Management LLC acquired a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $29,000. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on UNH. The Goldman Sachs Group boosted their price target on shares of UnitedHealth Group from $435.00 to $490.00 and gave the stock a “buy” rating in a report on Friday, July 17th. Zacks Research cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Monday, September 14th. Piper Sandler boosted their price objective on shares of UnitedHealth Group from $502.00 to $504.00 and gave the company an “overweight” rating in a research report on Wednesday, October 14th. Wall Street Zen upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Finally, Bank of America reaffirmed a “buy” rating and set a $450.00 price objective on shares of UnitedHealth Group in a research report on Monday, July 20th. Twenty equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $463.93.

View Our Latest Research Report on UnitedHealth Group

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.19% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $403.10 on Wednesday. UnitedHealth Group Incorporated has a fifty-two week low of $255.96 and a fifty-two week high of $461.62. The firm’s 50-day simple moving average is $390.47 and its two-hundred day simple moving average is $363.08. The stock has a market cap of $361.81 billion, a PE ratio of 23.02, a price-to-earnings-growth ratio of 1.45 and a beta of 0.51. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.14 by $0.55. The firm had revenue of $112.72 billion during the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business’s revenue was down .4% on a year-over-year basis. During the same period last year, the business earned $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were issued a dividend of $2.32 per share. The ex-dividend date was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio is presently 53.00%.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

Positive Sentiment: Earnings and outlook are key tailwinds. UnitedHealth’s quarterly EPS and revenue beat analysts’ estimates, and the company raised its 2026 profit outlook. Those results helped drive an approximately 11% share gain over the month through October 30. UnitedHealth Just Gained 11% in a Month: Take Profits, or Buy More?
Positive Sentiment: Buying and value-oriented endorsements provide support. ETFs recorded net purchases of UnitedHealth shares, including $35 million in buying on October 29. BetterInvesting Magazine also named UNH its “Undervalued Stock,” though such selections are not a guarantee of future performance. UnitedHealth Group Draws ETF Buying BetterInvesting Magazine Update
Neutral Sentiment: Optum Insight’s AI investment is a longer-term opportunity with execution risk. UnitedHealth is expanding AI tools to improve efficiency and claims processing, but rising costs mean the spending still needs to translate into profit growth. Will UNH’s Optum Insight Spending Translate Into Profit Growth?
Negative Sentiment: Political scrutiny could weigh on sentiment. Senator Elizabeth Warren criticized the Trump administration’s approval of UnitedHealth’s $3.3 billion Amedisys acquisition, arguing the deal increases the company’s power over costs and patient care. The comments renew attention to potential regulatory and political risks. Elizabeth Warren Criticizes UnitedHealth’s Amedisys Deal

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.